References
- Thomas ED. Bone marrow transplantation from bench to bedside. In: Sackstein R, Janssen W, Elfenbein G, editors. Bone Marrow Transplantation: Foundations for the 21st Century. 1995; 34–41. New York Academy of Sciences. New York.
- Thomas ED. Some adventures in transplantation. Reminiscences of the past and thoughts for the future, International Society of Experimental Hematology, University of California, Davis, CA, December 1971. Exp Hematol (original series) 1972; 22: 7–9
- Glaser V. Investigator profile: E. Donnal Thomas, MD. J Hematother Stem Cell Res 2000; 9: 403–7
- Mayhall EA, Paffett-Lugassy N, Zon LI. The clinical potential of stem cells. Curr Opin Cell Biol 2004; 16: 713–20
- Rogers I, Casper RF. Umbilical cord blood stem cells. Best Pract Res Clin Obstet Gynaecol 2004; 18: 893–908
- McNiece I. In focus: cord blood. Cytotherapy 2005; 7: 207–8
- O'Donoghue K, Fisk NM. Fetal stem cells. Best Pract Res Clin Obstet Gynaecol 2004; 18: 853–75
- Doss MX, Koehler CI, Gissel C, et al. Embryonic stem cells: a promising tool for cell replacement therapy. J Cell Mol Med 2004; 8: 465–73
- Wobus AM, Boheler KR. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 2005; 85: 635–78
- Then SN. Stem cell technologies: regulation, patents and problems. J Law Med 2004; 12: 188–204
- Walters L. Human embryonic stem cell research: an intercultural perspective. Kennedy Inst Ethics J 2004; 14: 3–38
- Grewel SS, Kahn JP, MacMillan ML, et al. Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preimplantation genetic diagnosis. Blood 2004; 103: 1147–51
- Sharp JG. In focus: regulatory issues in cellular therapies. Cytotherapy 2003; 5: 277–313
- Regaldo A (with contributions from Kranhold K, Wysocki B). Big companies quietly pursue research on embryonic stem cells. Wall Street J 2005;71(12 April): A1 and A6.